These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 12542655)

  • 1. The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro.
    Cutler DJ; Haraura M; Reed HE; Shen S; Sheward WJ; Morrison CF; Marston HM; Harmar AJ; Piggins HD
    Eur J Neurosci; 2003 Jan; 17(2):197-204. PubMed ID: 12542655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrin-releasing peptide promotes suprachiasmatic nuclei cellular rhythmicity in the absence of vasoactive intestinal polypeptide-VPAC2 receptor signaling.
    Brown TM; Hughes AT; Piggins HD
    J Neurosci; 2005 Nov; 25(48):11155-64. PubMed ID: 16319315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus clock in vitro.
    Reed HE; Meyer-Spasche A; Cutler DJ; Coen CW; Piggins HD
    Eur J Neurosci; 2001 Feb; 13(4):839-43. PubMed ID: 11207820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vasoactive intestinal polypeptide on neurones of the rat suprachiasmatic nuclei in vitro.
    Reed HE; Cutler DJ; Brown TM; Brown J; Coen CW; Piggins HD
    J Neuroendocrinol; 2002 Aug; 14(8):639-46. PubMed ID: 12153466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons.
    Aton SJ; Colwell CS; Harmar AJ; Waschek J; Herzog ED
    Nat Neurosci; 2005 Apr; 8(4):476-83. PubMed ID: 15750589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats.
    Kalló I; Kalamatianos T; Piggins HD; Coen CW
    J Neuroendocrinol; 2004 Sep; 16(9):758-66. PubMed ID: 15344914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An essential role for peptidergic signalling in the control of circadian rhythms in the suprachiasmatic nuclei.
    Harmar AJ
    J Neuroendocrinol; 2003 Apr; 15(4):335-8. PubMed ID: 12622830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic approach reveals expression of the VPAC2 receptor in phenotypically defined neurons in the mouse suprachiasmatic nucleus and in its efferent target sites.
    Kalló I; Kalamatianos T; Wiltshire N; Shen S; Sheward WJ; Harmar AJ; Coen CW
    Eur J Neurosci; 2004 Apr; 19(8):2201-11. PubMed ID: 15090046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of vasoactive intestinal polypeptide in the mammalian circadian clock.
    Piggins HD; Cutler DJ
    J Endocrinol; 2003 Apr; 177(1):7-15. PubMed ID: 12697032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cell-Autonomous Clock of VIP Receptor VPAC2 Cells Regulates Period and Coherence of Circadian Behavior.
    Hamnett R; Chesham JE; Maywood ES; Hastings MH
    J Neurosci; 2021 Jan; 41(3):502-512. PubMed ID: 33234609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei.
    Harmar AJ; Marston HM; Shen S; Spratt C; West KM; Sheward WJ; Morrison CF; Dorin JR; Piggins HD; Reubi JC; Kelly JS; Maywood ES; Hastings MH
    Cell; 2002 May; 109(4):497-508. PubMed ID: 12086606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic stimulation of the hypothalamic vasoactive intestinal peptide receptor lengthens circadian period in mice and hamsters.
    Pantazopoulos H; Dolatshad H; Davis FC
    Am J Physiol Regul Integr Comp Physiol; 2010 Jul; 299(1):R379-85. PubMed ID: 20463182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupted neuronal activity rhythms in the suprachiasmatic nuclei of vasoactive intestinal polypeptide-deficient mice.
    Brown TM; Colwell CS; Waschek JA; Piggins HD
    J Neurophysiol; 2007 Mar; 97(3):2553-8. PubMed ID: 17151217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant gating of photic input to the suprachiasmatic circadian pacemaker of mice lacking the VPAC2 receptor.
    Hughes AT; Fahey B; Cutler DJ; Coogan AN; Piggins HD
    J Neurosci; 2004 Apr; 24(14):3522-6. PubMed ID: 15071099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Roles for VIP Neurons in the Neonatal and Adult Suprachiasmatic Nucleus.
    Mazuski C; Chen SP; Herzog ED
    J Biol Rhythms; 2020 Oct; 35(5):465-475. PubMed ID: 32536240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of vasoactive intestinal polypeptide in NMDA-induced phase delay of firing activity rhythm in the suprachiasmatic nucleus in vitro.
    Shibata S; Ono M; Tominaga K; Hamada T; Watanabe A; Watanabe S
    Neurosci Biobehav Rev; 1994; 18(4):591-5. PubMed ID: 7708374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro entrainment of the circadian rhythm of vasopressin-releasing cells in suprachiasmatic nucleus by vasoactive intestinal polypeptide.
    Watanabe K; Vanecek J; Yamaoka S
    Brain Res; 2000 Sep; 877(2):361-6. PubMed ID: 10986351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronization and maintenance of timekeeping in suprachiasmatic circadian clock cells by neuropeptidergic signaling.
    Maywood ES; Reddy AB; Wong GK; O'Neill JS; O'Brien JA; McMahon DG; Harmar AJ; Okamura H; Hastings MH
    Curr Biol; 2006 Mar; 16(6):599-605. PubMed ID: 16546085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide signaling differentially affects phase maintenance and rhythm generation in SCN and extra-SCN circadian oscillators.
    Hughes AT; Guilding C; Piggins HD
    PLoS One; 2011 Apr; 6(4):e18926. PubMed ID: 21559484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatiotemporal expression pattern of PERIOD 1 and PERIOD 2 in the mouse SCN is dependent on VIP receptor 2 signaling.
    Hannibal J; Norn THB; Georg B; Fahrenkrug J
    Eur J Neurosci; 2019 Oct; 50(7):3115-3132. PubMed ID: 31211910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.